TALPHERA, INC.
TLPH · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Wan Mark A: Form 4
Insider disclosure · Filed · Report period 22 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- TLPH · 00444T209 - Common Shares
Company details and SEC sources
CIK 0001427925 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TLPH on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1850 Gateway Drive, Suite 175, San Mateo, CA, 94404
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- ACELRX PHARMACEUTICALS INC (to 14 Dec 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields